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Clostridium butyricum strains that atypically produce the botulinum neurotoxin type
E (BoNT/E) possess a megaplasmid of unknown functions in their genome. In
this study, we cured two botulinum neurotoxigenic C. butyricum type E strains of
their megaplasmids, and compared the obtained megaplasmid-cured strains to their
respective wild-type parental strains. Our results showed that the megaplasmids do
not confer beta-lactam resistance on the neurotoxigenic C. butyricum type E strains,
although they carry several putative beta-lactamase genes. Instead, we found that the
megaplasmids are essential for growth of the neurotoxigenic C. butyricum type E strains
at the relatively low temperature of 15◦C, and are also relevant for growth of strains under
limiting pH and salinity conditions, as well as under favorable environmental conditions.
Moreover, the presence of the megaplasmids was associated with increased transcript
levels of the gene encoding BoNT/E in the C. butyricum type E strains, indicating that the
megaplasmids likely contain transcriptional regulators. However, the levels of BoNT/E in
the supernatants of the cured and uncured strains were similar after 24 and 48 h culture,
suggesting that expression of BoNT/E in the C. butyricum type E strains is not ultimately
controlled by the megaplasmids. Together, our results reveal that the C. butyricum type
E megaplasmids exert pleiotropic effects on the growth of their microbial hosts under
optimal and limiting environmental conditions, and also highlight the possibility of original
regulatory mechanisms controlling the expression of BoNT/E.
Keywords: neurotoxigenic Clostridium butyricum type E, megaplasmid, plasmid curing, microbial growth,
botulinum neurotoxin expression, PFGE, RTq-PCR
INTRODUCTION
Microorganisms of the Clostridium butyricum species have been attracting increasing interest
as they produce butyric acid which has many chemical, pharmaceutical and biotechnological
applications, and are capable of converting glycerol to 1,3-propanediol, a monomer of the
production of plastics (Szymanowska-Powałowska et al., 2014). Moreover, some C. butyricum
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strains have been shown to exert health benefits in humans and
animals and are therefore used as probiotics (Shinnoh et al., 2013;
Zhao et al., 2013).
However, certain C. butyricum strains produce the botulinum
neurotoxin (BoNT), which is one of the most toxic proteins
to humans and some vertebrate animals (Rossetto et al.,
2014). BoNT inhibits acetylcholine-mediated nerve-to-muscle
transmission thus leading to the flaccid paralysis typical of
botulism, a rare disease in humans that is mainly caused
by the ingestion of BoNT in contaminated food (foodborne
botulism), or by direct absorption of BoNT from the intestine
or a wound infected with BoNT-producing microorganisms
(intestinal toxemia botulism in infants or adults, and wound
botulism, respectively; Sobel, 2005).
Seven (A to G) BoNT serotypes sharing similar structures
and functions have long been recognized, based on specific
neutralization with distinct polyclonal antibodies (Hatheway,
1992), although a novel “hybrid” BoNT has recently been
described that is neutralized by existing antibodies (Barash
and Arnon, 2014; Maslanka et al., 2015). Except for BoNT/G,
which is produced by the rare C. argentinense species, the other
BoNT serotypes are formed by heterogeneous microorganisms
conventionally grouped within the C. botulinum species; BoNT/E
and BoNT/F can also be produced by sporadic strains of the
typically non-neurotoxigenic C. butyricum and C. baratii species,
respectively (Hatheway, 1992).
Neurotoxigenic C. butyricum type E strains have been isolated
from cases of intestinal toxemia botulism in infants and adults
in Italy, Japan, USA, Ireland, and UK (Aureli et al., 1986; Fenicia
et al., 1999, 2002; Abe et al., 2008; Dykes et al., 2015; Shelley et al.,
2015); foodborne botulism cases in China, India and Italy (Meng
et al., 1997; Chaudhry et al., 1998; Anniballi et al., 2002); food
and environmental samples (soil and lake shore) in China (Meng
et al., 1997, 1999); and, more recently, from pets (turtles) which
were identified as the likely source of infection in two infant
botulism cases in Ireland (Shelley et al., 2015).
By comparing the genome sequences of a neurotoxigenic
C. butyricum type E strain and two C. botulinum type E strains,
Hill et al. noted that the bont/e gene cluster – consisting of
the gene encoding BoNT/E and some accessory genes encoding
non-toxic proteins that assemble to BoNT/E to yield a toxin
complex – was inserted into the same chromosomal resolvase
(rarA) operon (Hill et al., 2009). Interestingly, all the inserted
sequences contained an intact rarA gene replacing the split
rarA gene: since resolvase is involved in the mobilization of
transposons, transposon-mediated horizontal gene transfer was
hypothesized to be responsible for the presence of the bont/e
gene cluster in the C. botulinum and C. butyricum species (Hill
et al., 2009). The subsequent finding that the bont/e gene cluster
is carried by plasmids in several C. botulinum type E strains
supports that it can reside within a variety of potentially mobile
genetic elements (Zhang et al., 2013).
We have recently shown that ten distinct neurotoxigenic
C. butyricum type E strains from Italy and China, all possessing
a chromosomal bont/e gene, share a very large plasmid of
different sizes in their genome: specifically, two megaplasmids
approximately 590 and 758 kb in size were identified among the
six Italian strains analyzed (Franciosa et al., 2011; Iacobino et al.,
2013). Given the high cost for the carriage and maintenance of
such megaplasmids, their consistent presence among the strains
could indicate that they play a crucial role in host physiology and
pathogenesis.
In this study, we cured two neurotoxigenic C. butyricum
type E strains from Italy of their differently sized megaplasmids,
and compared the wild-type (WT) parental strains with the
megaplasmid-cured (1mp) derivative strains in order to study
the megaplasmid function(s).
MATERIALS AND METHODS
Clostridium butyricum Strains and
Culture Conditions
Both neurotoxigenic C. butyricum type E strains used in this
study were from Italy. Strain ISS-21 was one of the isolates
from infant botulism cases that was first recognized as BoNT/E-
producing C. butyricum in 1985 (Aureli et al., 1986). Strain
ISS-190 was recovered from another infant botulism case that
occurred in 2001 (Fenicia et al., 2002). Strains ISS-21 and ISS-
190 possess megaplasmids that are 590 kb (mp590) and 758 kb
(mp758) in size, respectively, and they both carry an additional
smaller plasmid of ∼9 kb. The two strains have previously been
shown to be clonally related, with most of the genetic diversity
between the strains consisting of a ∼168 kb genetic region that
is present in the larger megaplasmid of strain ISS-190 and totally
missing from the smaller megaplasmid of strain ISS-21 (Iacobino
et al., 2013).
Clostridia strains were cultured in tryptone-peptone-glucose-
yeast extract (TPGY) broth (pH 7), or in TPGY agar plates or
egg yolk (EY) agar plates (Oxoid Ltd., Basingstoke, Hampshire,
England), and incubated at 37◦C under anaerobic conditions
(Anaerogen, Oxoid; 9–13% carbon dioxide and oxygen < 1%
according to the manufacturer), unless otherwise specified.
Curing Experiments and PCR Detection
of Plasmids
Strains ISS-21 and ISS-190 were sub-cultured repeatedly in fresh
TPGY broth tubes (5 ml) containing acridine orange (Sigma–
Aldrich, Milan, Italy) as a plasmid curing agent at increasing
concentrations from 3 to 16 µg/ml. The broth cultures were
incubated anaerobically at 37◦C overnight or until visible growth
was evident. At time intervals of two or three serial passages, the
broth cultures were spread onto EY agar plates and incubated
at 37◦C for 48 h under anaerobic conditions. Single colonies
were randomly picked from the EY agar plates and suspended
in 50 µl of 1XTE buffer (10 mM Tris, pH 8.0, and 0.1 mM
EDTA). Each colony suspension (5 µl) was directly used as a
DNA template in separate PCR reactions to detect four distinct
megaplasmid-encoded beta-lactamase genes (namely, latt, bl,
mb, and dp). The colonies that were PCR negative for the latt,
bl, mb, and dp genes were further analyzed by PCR for the
chromosome-encoded bont/e gene and the mob gene, which is
encoded by the smaller plasmid. The specific oligonucleotide
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primers used in the reactions and the PCR conditions were the
same as reported elsewhere (Franciosa et al., 2011; Iacobino et al.,
2013).
Pulsed-Field Gel Electrophoresis and
Southern Blot Experiments
Genomic DNA for pulsed-field gel electrophoresis (PFGE)
analyses was extracted from the WT and 1mp derivative
strains as described previously (Franciosa et al., 2011; Iacobino
et al., 2013). DNA samples were digested with XhoI or SmaI
(Roche Diagnostics, Milan, Italy) following the manufacturer’
instructions. The unrestricted and restricted DNA samples
were loaded on 1% GellyPhor PFGE agarose gel (Euroclone,
Milan, Italy); DNA isolated from Salmonella enterica serovar
Braenderup strain H9812 and restricted with XbaI (Roche
Diagnostics) served as the molecular standard (Hunter et al.,
2005). PFGE runs were performed using a contour-clamped
homogeneous electric field system (CHEF Mapper apparatus,
Bio-Rad Laboratories, Hercules, CA, USA). A constant
temperature of 14◦C was used, and the electrophoresis
parameters were as follows: voltage of 6 V/cm, an angle of
120, and switch times of 5–60 s (linear ramping factor) for 18 h
to separate the unrestricted DNA samples, or 4–40 s (linear
ramping factor) for 20 h to separate the restricted DNA samples.
Gels were stained with ethidium bromide and visualized with a
GelDoc 2000 apparatus (Bio-Rad Laboratories).
Southern hybridizations of pulsed-field gels with digoxigenin
(DIG)-labeled bont/E, beta-lactamase (latt), and mob gene probes
were carried out by using standard techniques (Franciosa et al.,
2011; Iacobino et al., 2013). The hybridized probes were detected
using DIG detection reagents (Roche Diagnostics) according to
the manufacturer’s instructions.
RNA Isolation, cDNA Synthesis, and
Quantitative Reverse Transcription PCR
For RNA isolation, the WT and 1mp derivative strains were
inoculated in TPGY broth (pH 7) and incubated anaerobically
at 37◦C: growth curves were generated by measuring the optical
density (OD)600 values at appropriate time intervals. Samples
were collected from the broth cultures at different time points and
centrifuged at 5000× g for 10 min at 4◦C, and the bacterial pellets
were then stored at−80◦C until RNA extraction.
RNA was extracted using the Total RNA Purification
Kit (Norgen Biotek Corporation, Thorold, ON, Canada).
A conventional on-column DNase digestion was performed
during the RNA purification protocol; to ensure elimination
of all contaminating DNA, the extracted RNA samples were
subjected to a second DNase treatment with the DNase – RNase
free kit (Roche Diagnostics) according to the manufacturer’s
instructions. The RNA concentration was determined using the
Qubit Fluorometer (Invitrogen, Carlsbad, CA, USA).
cDNA samples were prepared from 100 ng of RNA using
the QuantiTect Reverse Transcription kit according to the
manufacturer’s instructions (Qiagen, Chatsworth, CA, USA).
Negative reverse transcription (RT) controls were produced by
identical reaction conditions without reverse transcriptase.
Quantitative real-time PCR (RT-qPCR) was carried out in the
Rotor-Gene 6000 real-time thermal cycler (Qiagen). The primers
and probes used in this study for the target bont/e gene and for
the 16S rrn reference constitutive gene are listed in Table 1. The
reaction mixtures were composed of 1X SensiMix II Probe No-
ROX Kit (Bioline, Paris, France), 0,5 µM each primer, 0,2 µM
each probe and 2 ng cDNA, in a total volume of 20 µL.
The cycling conditions included 10 min at 95◦C, followed by
40 cycles of 95◦C for 15 s and 60◦C for 60 s. PCR efficiencies
were determined for each primer pair based on a standard
curve constructed from serial dilutions of cDNA samples. The
calculated efficiencies were 0.99 for 16S rrn and 0.92 for bont/e.
All reactions were performed in triplicate using RNA samples
from two independent extractions. Target gene transcript levels
were normalized to the 16S rrn transcript level and the relative
transcript changes were calculated using the 2−11Ct method
(Livak and Schmittgen, 2001).
Mouse Bioassay
The toxicity of BoNT/E produced by the cured and uncured
C. butyricum strains was quantified by mouse bioassay, i.e., the
most sensitive standard method for measuring active BoNTs
(Singh et al., 2013).
TPGY broth cultures (24 and 48 h) of the WT and 1mp
derivative strains were centrifuged at 12000 × g for 20 min at
4◦C. The supernatants were treated with 0.5% trypsin 1:250 (BD-
Difco, Milan, Italy) for 20 min at room temperature, in order
to activate the BoNT/E produced by the C. butyricum strains as
described by Kozaki et al. (1991); they were then fivefold diluted
in phosphate buffer (pH 6.4) containing 0.2% gelatin. Groups of
four CD1 mice (25 g weight) were injected intraperitoneally with
0.5 ml of the different dilutions per mice, and then monitored
TABLE 1 | Primers and probes for the target bont/e gene and for the 16S
rrn reference constitutive gene.
Primer or probe Sequence (5′→3′) Reference
bont/e (target gene)
Primers
BE1430F 5′-GTGAATCAGCACCTGG
ACTTTCAG-3′
Kimura et al.,
2001
BE1709R 5′-GCTGCTTGCACAGGT
TTATTGA-3′
Kimura et al.,
2001
Probe
BE1571FP (Probe) 5′-6-FAM -ATGCACAGAAAGT
GCCCGAAGGTGA-BHQ-1-3′
Kimura et al.,
2001
16S rrna (reference gene)∗
Primers
But_16S1 5′- CGTGTCGTGAGATG
TTGGGTTAA -3′
This work
But_16S2 5′- CGCGAGGTTGCAT
CTCATTGT -3′
This work
Probe
But_16S (Probe) 5′-HEX-ACTCTAGCGAGACT
GCCCGGGTT-BHQ-1-3′
This work
∗16S ribosomal RNA gene (locus tag CLP_RS20835) of Clostridium butyricum E4
strain BL5262 (GenBank Reference Number: NZ_ACOM01000011.1).
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over 4 days for signs of botulism (Centers for Disease Control
and Prevention, 1998). Survivals and deaths were recorded, and
the results were expressed as mouse 50% lethal dose (LD50) per
milliliter (Reed and Muench, 1938). The experimental protocol
was approved by the Italian Ministry of Health (Authorization
No. 291/2015).
Assessment of Growth Under Limiting
Salt, pH, and Temperature Conditions
The WT and1mp derivative strains were cultured in fresh TPGY
broth tubes that were either supplemented with 3% (w/v) sodium
chloride (NaCl), or adjusted to a pH of 5 with 6 N HCl, in order to
compare their growth under limiting salt concentrations and pH
values, respectively. The TPGY broth cultures were anaerobically
incubated at 37◦C for 8 days.
In separate sets of experiments, the WT and 1mp derivative
strains were inoculated in plain TPGY broth tubes, covered with
a layer of sterile vaseline oil to produce anaerobiosis conditions,
and incubated at 15◦C in a recirculating refrigerated water bath
(Haake G, ThermoScientific, Karlsruhe, Germany), in order to
compare their growth under limiting conditions of temperature.
In all experiments, the initial clostridia inocula were adjusted
to OD600 ∼0.2–0.3 using a spectrophotometer (Biophotometer,
Eppendorf, Milan, Italy). Growth curves were generated by
measuring the OD600 values of the broth cultures at appropriate
intervals of time. All growth experiments were performed in
triplicate.
Sugar Fermentation
We evaluated the sugar fermentation patterns by using a basal
medium consisting of tryptone (15 g/l), yeast extract (7 g/l),
L-cystine (0.25 g/l), sodium chloride (2.5 g/l), ascorbic acid
(0.1 g/l), sodium thioglycollate (0.5 g/l), bromothymol blue
(0.01 g/l), and agar (0.75 g/l), which was supplemented with
one of the following carbohydrates: glucose, maltose, mannitol,
mannose, xylose, glycerol, lactose, fructose, L-arabinose,
rhamnose, starch, sucrose, galactose, or cellobiose. Each
carbohydrate was added at a final concentration of 0.6% (w/v),
except for starch which was added at a final concentration
of 0.25% (Dowell et al., 1977). Tubes containing each sugar
fermentation medium (7 ml) were inoculated with 2% (v/v)
overnight TPGY broth cultures of the WT and 1mp derivative
strains, and incubated anaerobically for 48 h at 37◦C. The
fermentation was considered positive when the color of the
indicator (bromothymol blue) turned from green to yellow
upon acidification due to carbohydrate fermentation. Sugar
fermentation assays were performed in duplicate.
Sporulation Assay
Single colonies of the WT and 1mp derivative strains were
picked from EY agar plates and inoculated into separate TPGY
broth tubes (10 ml), which were then heat shocked at 70◦C for
10 min and incubated anaerobically at 37◦C for 20 days in order
to allow efficient sporulation.
For spore enumeration, the broth cultures were heat treated at
70◦C for 10 min to eliminate any vegetative bacterial cells; 10-fold
dilutions were then prepared and plated in duplicate onto TPGY
agar plates. After 48 h anaerobic incubation at 37◦C the colony-
forming units (CFU) were counted on the TPGY plates. When
the CFU numbers were below detectable levels, the spores were
enumerated by the most probable number method (USDA-FSIS,
2014). Briefly, sets of three TPGY broth tubes were inoculated
with 10-fold dilutions of the heat shocked spore suspensions;
the tubes were then incubated at 37◦C for 48 h under anaerobic
conditions. Tubes with observable turbidity after incubation were
recorded as positive, and the purity of the positive cultures was
checked on EY agar plates.
The mean spore numbers were determined by combining the
data from three separate experiments.
Beta-Lactamase Production
Beta-lactamase production was assayed using Beta-Lactamase
Identification Sticks (Oxoid). Since beta-lactamase production
can be induced in some clostridia strains upon exposure to
beta-lactam antimicrobials (Hedberg and Nord, 1996), the beta-
lactamase activity of the WT and 1mp derivative strains
was evaluated with and without induction. For induction,
strains were sequentially transferred in TPGY broth containing
increasing concentrations of penicillin G or ampicillin (Sigma–
Aldrich), starting from 0.062 µg/ml. The broths with the highest
concentrations of beta-lactams that could support growth were
streaked on TPGY agar plates containing the same beta-lactams
concentrations. Colonies from the agar plates were directly
assayed for beta-lactamase production. Single colonies of the
beta-lactamase producing Staphylococcus aureus strain ATCC
29213 were used as the positive control on Brain Heart Infusion
agar plates (Oxoid).
Statistical Analyses
Student’s t-test was used to perform all pairwise comparisons
between the WT and 1mp derivative strains. All calculations
were performed with GraphPad Prism version 6 software
(GraphPad Software, San Diego, CA, USA), and p-values < 0.05
were considered statistically significant.
RESULTS
Isolation of 1mp Derivatives of the WT
Neurotoxigenic C. butyricum Type E
Strains
Single colonies that were PCR negative for the latt, bl, mb, and
dp beta-lactamase genes, but positive for the bont/e and mob
genes, were obtained from strains ISS-21 and ISS-190 after 11 and
24 successive transfers, respectively, in the presence of acridine
orange (data not shown). Since the four selected latt, bl, mb, and
dp beta-lactamase genes are located within the megaplasmids of
the WT C. butyricum type E strains, as previously reported based
on the analysis of the available draft genome sequences of two
Italian C. butyricum type E strains (GenBank Reference Numbers:
NZ_ACOM00000000.1 and NZ_ABDT00000000.1) and on the
genetic maps obtained for the megaplasmids (Iacobino et al.,
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2013), the negative beta-lactamase PCR results suggest the loss
of the megaplasmid. Conversely, the positive bont/e and mob
PCR products indicate that the same colonies retained both the
chromosomal bont/e gene and the smaller plasmid-encoded mob
gene (Franciosa et al., 2011). These colonies were then selected as
candidate1mp derivatives of the WT parental C. butyricum type
E strains, and megaplasmid removal in the cured candidates was
verified by PFGE and Southern blot analysis.
Figure 1A shows the PFGE patterns of the undigested
genomic DNA patterns of the WT and candidate1mp derivative
strains. Bands corresponding to the 590 and 758 kb megaplasmids
were visible in the undigested DNA patterns of the WT strains
ISS-21 and ISS-190, respectively, whereas they were absent from
the undigested DNA patterns of the respective derivative strains
(hereafter designated as ISS-211mp590 and ISS-1901mp758,
respectively), confirming successful megaplasmid removal in the
latter strains. On the contrary, the smaller plasmid band was
visible in the undigested DNA patterns of the WT strains as
well as in those of the 1mp derivative strains, indicating that
the smaller plasmid was present in the 1mp strains. However,
the PFGE analysis did not allow us to identify other mutations
possibly induced by acridine orange in the DNA of the 1mp
strains.
In the Southern blot experiments, the bont/e and mob gene
probes hybridized to the chromosome and smaller plasmid
bands, respectively, of all WT and 1mp strains (Figures 1B,D).
The DNA probe targeting the megaplasmid-encoded beta-
lactamase (latt) gene hybridized to the undigested and digested
DNA of the WT strains ISS-21 and ISS-190; conversely, they
failed to hybridize to either the undigested or digested DNA
of the derivatives ISS-211mp590 and ISS-1901mp758, thus
confirming that the latter strains lacked the megaplasmid-
encoded beta-lactamase genes, which is consistent with the
hypothesis that they had been cured of their megaplasmids
(Figures 1C and 2).
Expression of BoNT/E
To assess the difference between the transcription rates of the
chromosomal bont/e gene in the WT and1mp derivative strains,
the relative mRNA levels of bont/e were compared for each strain
during the mid-exponential, late-exponential, early stationary,
and mid-stationary growth phases.
Similar bont/e transcription curves as a function of time
were observed in the WT strains ISS-21 and ISS-190; in fact,
the relative transcript levels of bont/e were low during the
mid-exponential phase, reached a maximum in the transition
between the exponential and stationary phases, and then rapidly
declined during the mid-stationary phase (Figures 3A,B), as was
previously observed for C. botulinum strains of different types
(Bradshaw et al., 2004; Chen et al., 2008; Connan et al., 2013).
Conversely, the relative transcript levels of bont/e in the
1mp derivative strains remained consistently low at all tested
time points (Figures 3A,B). Specifically, the maximum transcript
levels of bont/e were up to 240-fold lower in the cured strain
ISS-211mp590 than in the parental strain ISS-21 (p < 0.01;
Figure 3A), and up to 18-fold lower in the cured strain ISS-
1901mp758 than in the parental strain ISS-190 (p < 0.05;
Figure 3B).
FIGURE 1 | Pulsed-field gel electrophoresis patterns of the undigested genomic DNA of the WT Clostridium butyricum type E strains and their 1mp
derivative strains (A), and Southern hybridization analyses using the bont/E gene probe (B), the latt gene probe (C), and the mob gene probe (D).
Strains ISS-21 (lane 1), ISS-211mp590 (lane 2), ISS-190 (lane 3), and ISS-1901mp758 (lane 4). Ms, molecular standard, XbaI-digested DNA from Salmonella
Braenderup strain H9812 (Hunter et al., 2005).
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FIGURE 2 | Pulsed-field gel electrophoresis patterns of the genomic DNA of the WT C. butyricum type E strains and their 1mp derivative strains
restricted with XhoI (lanes 1–4) and SmaI (lanes 5–8) (A), and Southern hybridization analysis using the latt gene probe (B). Strains ISS-21 (lanes 1 and
5); ISS-211mp590 (lanes 2 and 6); ISS-190 (lanes 3 and 7); ISS-1901mp758 (lanes 4 and 8). Ms, molecular standard, XbaI-digested DNA from Salmonella
Braenderup strain H9812 (Hunter et al., 2005).
To investigate whether megaplasmid curing affected
the production of BoNT/E, the toxicity of trypsin-treated
supernatants from the cultures of the WT and 1mp strains was
measured by a mouse bioassay after 24 and 48 h of culture, when
the highest botulinum toxin levels should be present (Bradshaw
et al., 2004; Couesnon et al., 2006). The results of the mouse
bioassay revealed that the toxicity levels of the WT and 1mp
strains supernatants were similar (approximately 103 mouse
LD50/ml after 24 h culture and 104 mouse LD50/ml after 48 h
culture; Figure 3C).
Growth Studies Under Favorable and
Limiting Environmental Conditions
The growth of the WT and 1mp derivative strains was first
monitored at OD600 under favorable environmental conditions,
with TPGY broth (pH 7) as the growth medium and incubation
at 37◦C under anaerobic atmosphere (Hatheway, 1992). In these
conditions, both the WT strains (ISS-21 and ISS-190) reached
similar maximum growth peak values after approximately 10 h
of incubation (Figures 3A,B). A longer lag phase (4 h vs. <2h)
and a faster exponential phase (6 h vs. ∼10 h) were observed
in the growth curve of the WT strain ISS-190 compared to
ISS-21. Under the same favorable environmental conditions, the
growth rates of the 1mp derivative strains were significantly
lower compared to their WT parental strains, reaching lower ODs
at each tested time point, including the maximum growth peaks
after 10 h of incubation (Figures 3A,B).
We then compared the growth of the WT and1mp derivative
strains under the specific limiting conditions of pH (5.0), NaCl
concentration (3%), and incubation temperature (15◦C), which
are values that are close to the minimum pH, salinity, and
temperature values reported for neurotoxigenic C. butyricum
type E, respectively (Peck, 2002). As expected, under each
limiting condition, both cured and uncured strains grew more
slowly than under the optimal conditions; consequently, the
experimental time periods were extended to 8 days under the
limiting conditions of pH and salinity, and to 20 days when
strains were incubated at 15◦C.
Similar results were observed when the growth curves of the
strains were compared at pH 5 (Figures 4A,B) or in the presence
of 3% NaCl (Figures 4C,D). Under both experimental conditions,
each 1mp derivative strain showed ODs lower than those of
their respective WT parental strain, and the differences became
statistically significant when they entered the exponential phase
and at all subsequent time points throughout the 8 days duration
of the experiments (Figure 4). The duration of the growth phases
were similar for the WT and 1mp derivative strains: specifically,
all cured and uncured strains reached their maximum growth
peak between days 3 and 4 at pH 5, and between days 5 and 6
in the presence of 3% NaCl (Figure 4).
Figure 5 shows the growth curves of the WT and 1mp
derivative strains, respectively, after incubation at 15◦C for
20 days. Both the WT strains ISS-21 and ISS-190 exhibited a
lag phase of approximately 4 days, after which they entered the
exponential phase until reaching their maximum growth peak
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FIGURE 3 | Growth curves and relative transcript levels of bont/e of strains ISS-21 and ISS-211mp590 (A) and of strains ISS-190 and ISS-1901mp758
(B). The bont/e transcript levels were normalized to the 16S rrn transcript level. Plotted values are means of three replicates. BoNT/E toxin levels expressed as
mouse LD50 in the supernatants of 24 and 48 h TPGY cultures of the WT and 1mp derivative strains (C). ∗P < 0.05.
at day 6; the ODs of both WT strains then declined (mortality
phase). Notably, no increase was observed in the ODs of either
the ISS-211mp590 or ISS-1901mp758 strains over the 20 days of
the experiment, indicating that the 1mp derivative strains were
not able to grow at 15◦C.
Beta-Lactamase Production, Sugar
Fermentation Patterns and Spore
Production
Neither the WT nor 1mp derivative strains displayed any
beta-lactamase activity, with or without induction; in fact,
exposure of the strains to beta-lactams did not induce beta-
lactamase production. Growth of the strains only occurred in
the presence of very low maximum concentrations of penicillin
or ampicillin (0.125 and 0.062 µg/ml, respectively), with no
detectable difference between the antibiotic susceptibilities of the
WT and1mp derivative strains.
The results of the sugar fermentation assays showed that the
WT C. butyricum type E strains ISS-21 and ISS-190 fermented all
the 14 carbohydrates analyzed; on the contrary, both the cured
derivatives, ISS-211mp590 and ISS-1901mp758, were unable to
ferment five carbohydrates, namely arabinose, glycerol, mannitol,
rhamnose, and xylose.
After 20 days of anaerobic incubation at 37◦C all analyzed
strains produced spores. Specifically, both WT strains (ISS-
21 and ISS-190) produced ∼102 spores/ml each, whereas
their derivatives (ISS-211mp590 and ISS-1901mp758) produced
∼104 spores/ml each; i.e., the 1mp derivative strains yielded
nearly 2 logs more viable spores than their WT parental strains.
DISCUSSION
In the present study, we demonstrated that two neurotoxigenic
C. butyricum type E strains could be cured of their megaplasmids
of 590 and 758 kb, respectively, without loss of viability, in
accordance with the general definition of plasmids as dispensable
genetic elements. Megaplasmid curing was achieved by chemical
treatment with acridine orange, which is also known to cause
frameshift mutations; however, these are very small changes
compared with loss of megaplasmids which constitute 13–19%
of the whole bacterial genome (Franciosa et al., 2011), hence
we assumed that the observed effects in the cured strains were
primarily caused by the megaplasmid loss. Spontaneous loss of
megaplasmids did not occur and another curing strategy, i.e.,
repeated sub-culturing at 44◦C, a method previously used for
curing the plasmids of C. botulinum strains (Eklund et al., 1988),
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FIGURE 4 | Growth curves of WT and 1mp derivative strains at pH 5 (A,B) or in the presence of 3% NaCl (C,D). Plotted values are means of three
replicates. Error bars represent the standard deviations of the mean. ∗P < 0.05.
FIGURE 5 | Growth curves at 15◦C of strains ISS-21 and ISS-211mp590 (A); and ISS-190 and ISS-1901mp758 (B). Plotted values are means of three
replicates. Error bars represent the standard deviations of the mean. ∗P < 0.05.
did not work (data not shown). These observations imply that
the megaplasmids are inherently stable in their microbial hosts,
further supporting the existence of essential reasons other than
viability for the maintenance of the megaplasmids.
Since the most significant characteristic of the neurotoxigenic
C. butyricum type E strains is their ability to produce BoNT/E, we
first investigated whether the megaplasmids affected expression
of BoNT/E, a property that had not yet been documented in
the peculiar neurotoxigenic C. butyricum type E strains. Our
RTq-PCR results showed significantly higher amounts of bont/e
mRNA in both the WT strains than in their 1mp derivative
strains, and that the difference between the transcript levels
of bont/e was more pronounced when the strain possessing
the smaller megaplasmid was compared to its cured derivative.
These results indicate that transcriptional activators of the
chromosomal bont/e gene are likely present in the genetic region
common to the differently sized megaplasmids, while the 168 kb
genetic region unique to the larger megaplasmid possibly harbors
down-regulators of bont/e gene transcription. In silico analysis of
the genetic region common to the megaplasmids revealed that
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it contains several putative transcriptional regulatory elements,
including a sigma factor and six two-component systems (TCSs),
whereas five additional TCSs and a CRISPR-cas locus that has
also been demonstrated to play regulatory roles in some bacteria
(Sampson and Weiss, 2014) are located in the 168 kb genetic
region only present in the larger megaplasmid.
Most notably, however, we found that the variation in the
transcript levels of bont/e did not reflect variation in the levels
of BoNT/E produced by strains after 24 and 48 h culture:
in fact, despite the significantly higher transcript levels of
the bont/e gene in the WT strains compared to the 1mp
derivative strains, BoNT/E production as tested by the mouse
bioassay did not substantially differ between the WT and 1mp
derivative strains. These findings suggest that the megaplasmids
do not ultimately control the BoNT/E production; besides, they
could indicate that currently unknown downstream controls
at the post-transcriptional or translational levels and/or on
protein folding, secretion and degradation could exert a major
influence on the expression of BoNT/E by the neurotoxigenic
C. butyricum strains. The latter deduction would be in line with
the accumulating evidence that levels of control occurring after
mRNA formation play a more significant role in the regulation of
protein formation than previously appreciated (Foss et al., 2011;
Vogel and Marcotte, 2012). However, this hypothesis will need
to be confirmed by comparing the kinetic patterns of BoNT/E
production by the WT and cured strains.
Relatively little is known about the regulation of BoNT
production in neurotoxigenic clostridia strains. Expression of
BoNT/A in the C. botulinum strain Hall, which is the most
studied strain in this field, has been shown to be mainly regulated
at the transcriptional level by an alternative sigma factor
encoded by the botR gene and by several TCSs (Connan et al.,
2013; Connan and Popoff, 2015). Nevertheless, the BoNT/E-
producing C. butyricum and C. botulinum strains lack botR
gene homologs in their genomes, suggesting the existence of
alternative regulatory strategies for BoNT/E expression in these
strains (Connan et al., 2013).
Another major finding of this study was that growth of
the neurotoxigenic C. butyricum type E strains cured of their
megaplasmids was totally impaired at the moderately low
temperature of 15◦C, clearly indicating that both the differently
sized megaplasmids are essential for the adaptation of their hosts
to low temperatures. Different TCSs have been involved in cold
tolerance and adaptation of C. botulinum strains (Lindström
et al., 2012; Derman et al., 2013; Mascher et al., 2014); thus,
it may be interesting to assess whether one or more of the
TCSs of the megaplasmids, particularly those encoded by the
shared genetic region, play(s) similar roles in the neurotoxigenic
C. butyricum type E strains. Although the environmental source
of the clinical C. butyricum type E strains used in this study
was not originally identified, other neurotoxigenic C. butyricum
type E strains have been isolated from lake sediments and
aquatic animals (Meng et al., 1999; Shelley et al., 2015),
suggesting that these microorganisms are widespread in aquatic
environments, as for the C. botulinum type E strains (Horowitz,
2010; Espelund and Klaveness, 2014). Our findings are consistent
with those of a recent study that predicted an adaptive role for
plasmids of psychrophilic and psychrotolerant bacteria based
on in silico meta-analysis of the plasmid sequences (Dziewit
and Bartosik, 2014). Of note, the ability of the C. butyricum
type E strains to grow at 15◦C has also impacts on food
safety issues, for instance if temperature abuse occurs during
storage.
In addition, we found that growth of the1mp neurotoxigenic
C. butyricum type E strains was significantly lower than for
the WT strains at optimal environmental conditions, as well as
under limiting conditions of pH and salt concentrations. The loss
of such large plasmids likely results in pleiotropic effects, thus
impairing metabolism and modifying the physiologic efficiency
of the host bacteria.
Our finding that the strains lacking the megaplasmids were
unable to ferment several carbohydrates, including glycerol,
confirms that the megaplasmids play a role in multiple metabolic
pathways; this is also supported by the fact that the annotated
sequence of the megaplasmid (contig 1 of GenBank Reference
NZ_ACOM00000000.1) contains a number of genes for sugar
metabolism, including a complete 1,3-propanediol operon
(9182 bp in length) potentially involved in the fermentation of
glycerol.
Interestingly, under identical conditions, larger spore
numbers were produced by the 1mp derivative strains than by
their WT parental strains. Since the1mp strains are less fit under
certain environmental conditions, as discussed above, they may
have developed greater spore-forming ability in order to survive;
however, this remains a speculative hypothesis, and further
research is needed on the regulatory mechanisms controlling
sporulation in these strains.
Finally, we compared the WT and 1mp derivative strains
for beta-lactamase production. We had previously hypothesized
that the megaplasmids may confer resistance to beta-lactam
antibiotics mediated by beta-lactamases to their microbial hosts
because the genetic region common to the larger and smaller
megaplasmids contains at least four putative beta-lactamase
genes (Franciosa et al., 2011; Iacobino et al., 2013). However,
our present results showed that neither the WT nor 1mp
derivative strains produced beta-lactamases, even after induction,
and that all cured and uncured strains were highly susceptible
to penicillin G and ampicillin, i.e., two of the most widely used
beta-lactam antibiotics. Thus, these results indicate that either the
megaplasmid-encoded beta-lactamase genes are inactive because
of mutations or their expression is repressed.
CONCLUSION
We have demonstrated that the megaplasmids of neurotoxigenic
C. butyricum type E strains are not related to beta-lactam
resistance, and nor do they ultimately control the synthesis of
BoNT/E; rather, they encode functions that are relevant for the
growth of their hosts under optimal and limiting environmental
conditions, and that are critical for growth at low temperatures.
Future efforts should focus on the characterization of the
megaplasmid genes and their impact on specific phenotypes
as well as on the megaplasmids mobility properties, transfer
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efficiencies and host range, in order to decipher their role in the
emergence and spread of their microbial hosts.
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